Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
All News
Headline News
Benzinga
Chartmill
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
StockStory
Stocktwits
Talk Markets
Press Releases
24-7 Press Release
AB Newswire
ACCESSWIRE
ACN Newswire
Authority Press Wire
Binary News Network
Brandpoint
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
eTrendy Stock
EZ Newswire
FinancialNewsMedia
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
News Direct
Newsfile
NewsUSA
Newswire.com
Newsworthy.ai
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
Syndication Cloud
TheNewswire
Zexprwire
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)
December 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Atsena Therapeutics Announces Dosing Completed in Part A of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 to Treat X-linked Retinoschisis
December 16, 2024
From
Atsena Therapeutics
Via
GlobeNewswire
Brixton Metals Discovers Multiple Porphyry Systems at the North Target on its Thorn Project
December 16, 2024
From
Brixton Metals Corporation
Via
GlobeNewswire
Tickers
BBBXF
TSX-V:BBB
OTC Markets Group Welcomes Nevada Canyon Gold Corp to OTCQX
December 16, 2024
From
OTC Markets
Via
GlobeNewswire
Tickers
NGLD
OTCM
Webuy Advances to Next Phase of NVIDIA’s AI Accelerator Program
December 16, 2024
From
Webuy Global Limited
Via
GlobeNewswire
Tickers
WBUY
Amarin Receives National Reimbursement for VAZKEPA® in Italy
December 16, 2024
From
Amarin Corporation plc
Via
GlobeNewswire
Tickers
AMRN
Hydreight Updates on VSDHOne: Revolutionizing Direct-to-Consumer Healthcare Across All 50 States
December 16, 2024
From
Hydreight Technologies Inc.
Via
GlobeNewswire
Tickers
HYDTF
TSX-V:NURS
Precision Neuroscience Raises $102 Million to Advance AI-Powered Brain Implant
December 16, 2024
From
Precision Neuroscience
Via
GlobeNewswire
Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus’ First Gene Edited Weed Management Solution for U.S. Rice Growers
December 16, 2024
From
Cibus US LLC
Via
GlobeNewswire
Tickers
CBUS
Barrick Update on Mali Operations
December 16, 2024
From
Barrick Gold Corporation
Via
GlobeNewswire
Tickers
GOLD
TSX:ABX
Foghorn Therapeutics Provides Update on FHD-286 Clinical Development Program and Strategic Priorities
December 16, 2024
From
Foghorn Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FHTX
LEEF Brands to Become One of the First Publicly Traded Cannabis Company to Integrate Bitcoin into its Treasury Reserve via US$5 Million Bitcoin-Backed Debenture Offering
December 16, 2024
From
LEEF Brands Inc.
Via
GlobeNewswire
Tickers
CSE:LEEF
LEEED
LEEEF
Verge Genomics Announces New Development Candidate, VRG201, a Novel Maintenance Therapy for Long-Term Weight Management
December 16, 2024
From
Verge Genomics
Via
GlobeNewswire
Parsons Successfully Conducts First-Of-A-Kind Threat Environment Demonstration
December 16, 2024
From
Parsons Services Company
Via
GlobeNewswire
Tickers
PSN
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)
December 16, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
Calian US, Inc. Expands Leadership Team with Addition of Prominent Industry Veterans
December 16, 2024
From
Calian Group Ltd.
Via
GlobeNewswire
Tickers
TSX:CGY
Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development
December 16, 2024
From
Brains Bioceutical Corp
Via
GlobeNewswire
ParaZero Regains Compliance with Nasdaq Minimum Bid Price Rule
December 16, 2024
From
ParaZero Technologies Ltd.
Via
GlobeNewswire
Tickers
PRZO
Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships
December 16, 2024
From
Atea Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
AVIR
Fortuna extends Kingfisher deposit with drill intersect of 4.1 g/t Au over 15.3 meters at the Séguéla Mine, Côte d’Ivoire
December 16, 2024
From
Fortuna Mining Corp.
Via
GlobeNewswire
Tickers
FSM
TSX:FVI
Premiere of documentary "Your Voice" on Swift Response to Public Complaints to be held
December 16, 2024
From
The Organizing Committee of The 2024 Beijing Forum on "Swift Response to Public Complaints"
Via
GlobeNewswire
2024 Imperial Springs International Forum Emphasizes Collective Action to Address Global Challenges
December 16, 2024
From
The 2024 Imperial Springs International Forum (ISIF)
Via
GlobeNewswire
Nokia and EOLO deploy Europe’s first 5G standalone mmWave network in Italy
December 16, 2024
From
Nokia Oyj
Via
GlobeNewswire
Quantexa Recognized as Category Leader in Chartis’ 2024 AML Transaction Monitoring Solutions Report
December 16, 2024
From
Quantexa
Via
GlobeNewswire
CEO Update to Shareholders
December 16, 2024
From
Leading Edge Materials Corp.
Via
GlobeNewswire
Tickers
LEMIF
TSX-V:LEM
Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million
December 16, 2024
From
INVENTIVA
Via
GlobeNewswire
EUR 200 million share buyback completed
December 16, 2024
From
Aegon Ltd.
Via
GlobeNewswire
Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
December 16, 2024
From
Akoustis, Inc.
Via
GlobeNewswire
Tickers
AKTS
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States
December 16, 2024
From
Basilea Pharmaceutica AG, Allschwil
Via
GlobeNewswire
Roadzen Inc. Announces Pricing of Public Offering
December 15, 2024
From
Roadzen Inc.
Via
GlobeNewswire
Tickers
RDZN
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.